Vizora日本語

Kohjin BioKohjin Bio Co., Ltd.177A東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP

Which Kohjin Bio businesses make the profit?

Revenue by business segment, and the profit each one keeps.

Revenue by geography

Geographic revenue reported in annual filings

No geographic revenue breakdown was disclosed.

※ Segment figures include inter-segment sales and do not sum to the company total

Revenue and profit mix

FY ending Mar 2026

Revenue mix

Profit mix (profitable segments)

Tissue culture business accounts for 51% of revenue and 92% of profit.

Loss-making segments (excluded from profit bar)

Microbiological business: -¥94.6M

Calculated from disclosed figures; listed by margin. Difference = profit share − revenue share (percentage points). Segment revenues may include inter-segment sales and may not sum to company revenue.

Business growth × margin

X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.

Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.

Segment history (JPY millions)

SegmentRevenue CAGRFY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Tissue culture business+15.5%3y1,64931.6%1,90432.0%2,26933.7%2,54037.3%
Microbiological business-15.9%3y2,39734.1%1,656-4.2%1,78224.7%1,425-6.6%
Cell process business+11.8%3y69740.3%1,20939.0%1,15527.1%9758.2%

Top: revenue. Bottom: operating margin.

Sources

Show source documents (3)

  • EDINET (FSA Japan)

    有価証券報告書－第45期(2025/04/01－2026/03/31)

    ID S100YB5D2026-06-23Open

  • EDINET (FSA Japan)

    有価証券報告書－第44期(2024/04/01－2025/03/31)

    ID S100W2HI2025-06-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第43期(2023/04/01－2024/03/31)

    ID S100TX402024-06-28Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image